Advertisement

Lidocaine with Epinephrine Injection

[02 December 2016]

Products Affected - Description

Lidocaine (with epinephrine 1:100,000) injection, Hospira
1%, 30 mL vial, 100 count (NDC 00409-3178-02)
1%, 50 mL vial, 100 count (NDC 00409-3178-03)
 
Lidocaine (with epinephrine 1:200,000) injection, Hospira
0.5%, 50 mL vial, 100 count (NDC 00409-3177-01)

Xylocaine (with epinephrine 1:200,000) injection, Fresenius Kabi
0.5%, 50 mL vial, 25 count (NDC 63323-0481-57)
1%, 10 mL vial, 25 count (NDC 63323-0482-17)
1%, 20 mL vial, 25 count (NDC 63323-0482-27)
1%, 50 mL vial, 25 count (NDC 63323-0482-57)
 
Xylocaine-MPF (with epinephrine 1:200,000) injection, Fresenius Kabi
1%, 10 mL vial, 25 count (NDC 63323-0487-17)
1%, 30 mL vial, 25 count (NDC 63323-0487-37)
1.5%, 10 mL vial, 25 count (NDC 63323-0488-17)
2%, 10 mL vial, 25 count (NDC 63323-0489-17)
2%, 20 mL vial, 25 count (NDC 63323-0489-27)

Reason for the Shortage

  • Fresenius Kabi has Xylocaine with epinephrine presentations on shortage due to increased demand for the product and manufacturing delays.
  • Hospira has lidocaine with epinephrine presentations on shortage due to manufacturing delays.

Available Products

Lidocaine (with epinephrine 1:100,000) injection, Hospira
1%, 20 mL vial, 100 count (NDC 00409-3178-01)
2%, 20 mL vial, 100 count (NDC 00409-3182-01)
2%, 30 mL vial, 100 count (NDC 00409-3182-02)
2%, 50 mL vial, 100 count (NDC 00409-3182-03)
 
Lidocaine (with epinephrine 1:200,000) injection, Hospira
1.5%, 5 mL glass ampule, 10 count (NDC 00409-1209-01)
1.5%, 30 mL vial, 25 count (NDC 00409-3181-01)
2%, 20 mL vial, 25 count (NDC 00409-3183-01)
 
Xylocaine (with epinephrine 1:200,000) injection, Fresenius Kabi
2%, 20 mL vial, 25 count (NDC 63323-0483-27)
2%, 50 mL vial, 25 count (NDC 63323-0483-57)
 
Xylocaine-MPF (with epinephrine 1:200,000) injection, Fresenius Kabi
1%, 30 mL vial, sterile-pack 5 count (NDC 63323-0487-31)
1.5%, 30 mL vial, sterile-pack 5 count (NDC 63323-0488-31)
1.5%, 30 mL vial, 25 count (NDC 63323-0488-37)
2%, 20 mL vial, sterile-pack 5 count (NDC 63323-0489-21)

Estimated Resupply Dates

  • Hospira has 1% lidocaine with epinephrine (1:100,000) 30 mL and 50 mL vials on back order and the company estimates a release date of early-January 2017 for the 30 mL vials and late-December 2016 for the 50 mL vials.
  • Hospira has 0.5% lidocaine with epinephrine (1:200,000) 50 mL vials on back order and the company estimates a release date of late-December 2016.
  • Fresenius Kabi has 0.5% Xylocaine with epinephrine (1:200,000) 50 mL vials on back order and the company estimates a release date of early-December 2016. Fresenius Kabi has 1% Xylocaine with epinephrine (1:200,000) 10 mL, 20 mL, and 50 mL vials on back order and the company estimates a release date of mid-April 2017 for the 10 mL vials and early-December 2016 for the 20 mL and 50 mL vials. The 1% Xylocaine-MPF with epinephrine (1:200,000) 10 mL and 30 mL vials are on back order and the company estimates a release date of mid-April 2017 for the 10 mL vials and early-December 2016 for the 30 mL vials. The 1.5% Xylocaine-MPF with epinephrine (1:200,000) 10 mL vials are on back order and the company estimates a release date of mid-April 2017. The 2% Xylocaine-MPF with epinephrine (1:200,000) 10 mL and 20 mL vials are on back order and the company estimates a release date of mid-April 2017 for the 10 mL vials and early-December 2016 for the 20 mL vials.

Related Shortages

Updated

December 2, November 11 and 4, May 26, 2016; August 6, July 17, June 25, May 11, April 15, March 27, February 20 and 3, January 23 and 7, 2015; December 18, 12 and 1, November 20 and 14, October 31 and 14, September 10 and 5, August 28, July 25, 17 and 3, June 11, May 28, 12 and 1, April 9, March 27 and 7, February 27 and 7, January 21, 14 and 6, 2014; December 13, November 27 and 15, October 31 and 9, September 18 and 3, August 13, July 1, June 26, 10 and 6, May 9, April 23 and 9, March 27, February 28 and 5, January 16, 2013; December 12, November 9, October 25 and 17, August 22 and 9, June 21, May 30, April 16, March 7, February 22 and 8, January 25 and 3, 2012; December 16, 2011, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement
ASHP Product Listing